Digestase 2.0
Natural health product licensed in Canada
- Other names
- Digestase, Digestase II
- Licence holder
- Advanced Orthomolecular Research Inc.
- NPN or DIN-HM
- 80036178
- Status
- Active licence
- Licence date
- 4 October 2012
- Revision date
- 11 April 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 3,000 FCC ALU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 30 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 86.7 FCC AGU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 8.7 mg | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 9.4 mg | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 10.1 FCC SAPU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 250 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 12.5 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 250 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier | 12.5 mg | Not calculated |
Non-medicinal ingredients
D-Mannitol, Dioxyde de silicium, Hypromellose, Maltodextrine, Poudre de racine de carotte, Cellulose microcristalline, Dextrine, Citrate de sodium, Eau purifiée, Sodium Stearyl Fumarate, Chlorure de sodium, Gluconate de calcium, Fluorure de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive aid that reduces gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains), prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates. Digestive enzyme/lactase to assist in the digestion of foods containing lactose (e.g. dairy foods, milk). Helps prevent symptoms of lactose intolerance (including gas, bloating, cramping and diarrhea).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80036178
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.